Multimodal data fusion for cancer biomarker discovery with deep learning

S Steyaert, M Pizurica, D Nagaraj… - Nature machine …, 2023 - nature.com
Technological advances have made it possible to study a patient from multiple angles with
high-dimensional, high-throughput multiscale biomedical data. In oncology, massive …

[HTML][HTML] The world cancer research fund/American institute for cancer research third expert report on diet, nutrition, physical activity, and cancer: impact and future …

SK Clinton, EL Giovannucci, SD Hursting - The Journal of nutrition, 2020 - Elsevier
ABSTRACT The Third Expert Report on Diet, Nutrition, Physical Activity, and Cancer: A
Global Perspective by the World Cancer Research Fund (WCRF) and the American Institute …

A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions

TN Jarada, JG Rokne, R Alhajj - Journal of cheminformatics, 2020 - Springer
Drug repositioning is the process of identifying novel therapeutic potentials for existing drugs
and discovering therapies for untreated diseases. Drug repositioning, therefore, plays an …

Emergence of a high-plasticity cell state during lung cancer evolution

ND Marjanovic, M Hofree, JE Chan, D Canner, K Wu… - Cancer cell, 2020 - cell.com
Tumor evolution from a single cell into a malignant, heterogeneous tissue remains poorly
understood. Here, we profile single-cell transcriptomes of genetically engineered mouse …

Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm

Y Nakamura, A Kawazoe, F Lordick… - Nature reviews Clinical …, 2021 - nature.com
Advances in cancer biology and sequencing technology have enabled the selection of
targeted and more effective treatments for individual patients with various types of solid …

Tumor-infiltrating lymphocytes and their prognostic value in cutaneous melanoma

F Maibach, H Sadozai, SM Seyed Jafari… - Frontiers in …, 2020 - frontiersin.org
Recent breakthroughs in tumor immunotherapy such as immune checkpoint blockade (ICB)
antibodies, have demonstrated the capacity of the immune system to fight cancer in a …

The chromatin accessibility landscape of primary human cancers

MR Corces, JM Granja, S Shams, BH Louie… - Science, 2018 - science.org
INTRODUCTION Cancer is one of the leading causes of death worldwide. Although the 2%
of the human genome that encodes proteins has been extensively studied, much remains to …

Promises and challenges of adoptive T-cell therapies for solid tumours

M Morotti, A Albukhari, A Alsaadi, M Artibani… - British journal of …, 2021 - nature.com
Cancer is a leading cause of death worldwide and, despite new targeted therapies and
immunotherapies, many patients with advanced-stage-or high-risk cancers still die, owing to …

Applications of proteomics in ovarian cancer: dawn of a new era

A Ghose, SVN Gullapalli, N Chohan, A Bolina… - Proteomes, 2022 - mdpi.com
The ability to identify ovarian cancer (OC) at its earliest stages remains a challenge. The
patients present an advanced stage at diagnosis. This heterogeneous disease has …

New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx

M Mounir, M Lucchetta, TC Silva, C Olsen… - PLoS computational …, 2019 - journals.plos.org
The advent of Next-Generation Sequencing (NGS) technologies has opened new
perspectives in deciphering the genetic mechanisms underlying complex diseases …